BDBM489617 (R)-4-(4-amino-8- fluoro-6,7-dimethoxy- quinazolin-2-yl)-1- (3-(ethylamino)-3- (4-fluorophenyl)- propanoyl)-1,2,5,6- tetrahydropyridine- 3-carboxylate::US10961252, Cmp No. 6::US11248000, Cmp No. 6
SMILES CCN[C@H](CC(=O)N1CCC(=C(C1)C(=O)OC)c1nc(N)c2cc(OC)c(OC)c(F)c2n1)c1ccc(F)cc1
InChI Key InChIKey=LMABCHDIMVLLFZ-HXUWFJFHSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 489617
TargetCobra venom factor/Complement factor B/Complement factor D(Naja kaouthia (Monocled cobra) (Naja siamensis))
Achillion Pharmaceuticals
US Patent
Achillion Pharmaceuticals
US Patent
Affinity DataIC50: 5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair
Affinity DataIC50: 5.50E+3nMAssay Description:CVF-Bb complex is prepared from purified cobra venom factor (1 μM); human Complement factor B and human Complement factor D are available from a...More data for this Ligand-Target Pair